ANI Pharmaceuticals
ANIP
ANIP
151 hedge funds and large institutions have $305M invested in ANI Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
89% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $9.86M
Holders
151
Holding in Top 10
–
Calls
$1.11M
Puts
$9.86M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$7.57M | |
| 3 | +$4.6M | |
| 4 |
Morgan Stanley
New York
|
+$2.8M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.67M |
Top Sellers
| 1 | -$7.56M | |
| 2 | -$6.06M | |
| 3 | -$5.46M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.12M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$2.89M |